[ad_1]

SOUTH SAN FRANCISCO, Calif., Oct. 6, 2023 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel’s Inducement Plan, approved by the Compensation Committee of Rigel’s Board of Directors and granted as an inducement…

[ad_2]